| 1 |
28744398 | Kinase inhibitors of HER2/AKT pathway induce ERK phosphorylation via a FOXO-dependent feedback loop. | 2017 |
4 |
| 2 |
26623720 | Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients. | 2016 Jan 5 |
1 |
| 3 |
23365119 | Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas. | 2013 May |
1 |
| 4 |
21464044 | The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models. | 2011 May 15 |
1 |
| 5 |
19853943 | Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK. | 2009 Dec |
2 |
| 6 |
16452222 | Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells. | 2006 Feb 1 |
1 |